Trade Summary

6 days ago, RA CAPITAL MANAGEMENT, L.P., serving as Dir at Artiva Biotherapeutics, Inc. (ARTV), purchased 531,326 shares at $8.66 per share, for a total transaction value of $4,599,903.46. Following this transaction, RA CAPITAL MANAGEMENT, L.P. now holds 16,763,043 shares of ARTV.

This purchase represents a 3.27% increase in RA CAPITAL MANAGEMENT, L.P.'s stake in the company. This is considered a medium-conviction trade.

The trade was executed on Friday, June 12, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, June 16, 2026 at 6:08 PM ET, 4 days after the trade was made.

Artiva Biotherapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.